Sort
16,300 grants matching “fatty liver disease”
Docosahexaenoic Acid Loaded Low-density Lipoproteins: A Novel Biologic Intervention for Hepatocellular Carcinoma.
$436,977Ian Ronald Corbin · Ut Southwestern Medical Center · R01 · FY2023 · CA
Leveraging arginase biology against metabolic disease
$436,856Brian Jesse Debosch · Washington University · R01 · FY2023 · DK
Cytokine and Metabolic Regulation of Adipose-tissue Tregs
$436,762Chaoran Li · Emory University · R01 · FY2024 · DK
CEACAM and Insulin Action
$436,728Sonia Michael Najjar · Ohio University Athens · R01 · FY2018 · DK
CEACAM and Insulin Action
$436,728Sonia Michael Najjar · Ohio University Athens · R01 · FY2019 · DK
CEACAM and Insulin Action
$436,728Sonia Michael Najjar · Ohio University Athens · R01 · FY2021 · DK
CEACAM and Insulin Action
$436,728Sonia Michael Najjar · Ohio University Athens · R01 · FY2020 · DK
Re-engineering a human 3D liver tissue model for non-alcoholic fatty liver disease for drug screening
$436,677Mark T. Miedel · University Of Pittsburgh At Pittsburgh · UH2 · FY2022 · TR
Mechanisms for Ceramide Mediated Vascular Dysfunction
$436,594John David Symons · University Of Utah · R15 · FY2012 · HL
Lymphatic remodeling and transport of dietary fats in short gut syndrome
$436,527Gwendalyn J Randolph · Washington University · R01 · FY2021 · DK
Lymphatic remodeling and transport of dietary fats in short gut syndrome
$436,527Gwendalyn J Randolph · Washington University · R01 · FY2022 · DK
Lymphatic remodeling and transport of dietary fats in short gut syndrome
$436,527Gwendalyn J Randolph · Washington University · R01 · FY2023 · DK
Long term efficacy and safety of orlistat for type 1 hyperlipoproteinemia: a randomized, double-blind, placebo-controlled trial
$436,509Abhimanyu Garg · Ut Southwestern Medical Center · R33 · FY2025 · HL
Liver Cancer Therapy by MiR-22 and Its Inducers
$436,506Yu-Jui Yvonne Wan · University Of California At Davis · R01 · FY2021 · CA
Hepatic steatosis promotes liver metastasis
$436,171Nidhi Rohatgi · Washington University · R01 · FY2025 · CA
Lymphatic remodeling and transport of dietary fats in short gut syndrome
$436,065Gwendalyn J Randolph · Washington University · R01 · FY2020 · DK
Regulation of Peroxisomal Metabolism by Lysine Acylation
$436,051Eric S Goetzman · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Environmental chemical exposures during pregnancy and women's cardio-metabolic health
$436,003Dana Dabelea · University Of Colorado Denver · R01 · FY2021 · ES
Mouse Metabolic Measurement System
$435,980Anthony W Ferrante · Columbia University Health Sciences · S10 · FY2022 · OD
Clinical development of a colon-targeted butyrate tablet to evaluate effects on cholesterol and trimethyl amine oxide in subjects at risk for cardiovascular disease
$435,882Jerzy Szewczyk · Biokier, Inc. · R43 · FY2024 · HL
Nonalcoholic Steatohepatittis Clinical Research Network (NASH CRN)
$435,547Arun J Sanyal · Virginia Commonwealth University · U01 · FY2019 · DK
Targeting the orphan nuclear receptor LRH-1 with small molecules
$435,530Eric A Ortlund · Emory University · R01 · FY2021 · DK
Chemical engineering of therapeutic RNAs for extrahepatic delivery
$435,500Anastasia Khvorova · Univ Of Massachusetts Med Sch Worcester · R35 · FY2023 · GM
Chemical engineering of therapeutic RNAs for extrahepatic delivery
$435,500Anastasia Khvorova · Univ Of Massachusetts Med Sch Worcester · R35 · FY2020 · GM
Chemical engineering of therapeutic RNAs for extrahepatic delivery
$435,500Anastasia Khvorova · Univ Of Massachusetts Med Sch Worcester · R35 · FY2022 · GM